EVIO (EVIO) EBITDA Margin %: 0.33% (As of Jun. 2020)


What is EVIO EBITDA Margin %?

EVIO EVIO -98.00% EBITDA Margin % is 0.33% as of Jun. 2020.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. EVIO's EBITDA for the three months ended in Jun. 2020 was $0.00 Mil. EVIO's Revenue for the three months ended in Jun. 2020 was $0.60 Mil. Therefore, EVIO's EBITDA margin for the quarter that ended in Jun. 2020 was 0.33%.

EVIO  (OTCPK:EVIO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

EVIO EBITDA Margin % Related Terms

EVIO EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for EVIO's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO EBITDA Margin % Chart

EVIO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19
EBITDA Margin %
-1,120.80 -381.11 -59.12 -221.39 -154.62

EVIO Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -110.72 -261.62 -66.17 -157.95 0.33

EVIO vs VCBD, ACCA, LITH: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EVIO's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EVIO EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EVIO's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where EVIO's EBITDA Margin % falls into.


EVIO EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

EVIO's EBITDA Margin % for the fiscal year that ended in Sep. 2019 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2019 )/Revenue (A: Sep. 2019 )
=-5.86/3.79
=-154.62 %

EVIO's EBITDA Margin % for the quarter that ended in Jun. 2020 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2020 )/Revenue (Q: Jun. 2020 )
=0.002/0.603
=0.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.33% mean?
EVIO (EVIO) has a EBITDA Margin % of 0.33% as of Jun. 2020. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EVIO and its competitors.
Is EVIO's EBITDA Margin % too high?
EVIO's current EBITDA Margin % is 0.33%. The Drug Manufacturers industry median EBITDA Margin % is 12.39. EVIO's value of 0.33% is 97.3% below this industry median.
How does EVIO's EBITDA Margin % compare to VCBD and ACCA?
EVIO's EBITDA Margin % of 0.33% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. EVIO's value of 0.33% is 97.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EVIO's current EBITDA Margin % of 0.33% is 97.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EVIO and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVIO's current EBITDA Margin % is 0.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current EBITDA Margin % of 0.33%. The current EBITDA Margin % is 0.33% and 97.3% below the Drug Manufacturers industry median of 12.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EVIO (EVIO), the current EBITDA Margin % is 0.33% as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.